158 related articles for article (PubMed ID: 25320014)
1. Targeting the c-Met/FZD8 signaling axis eliminates patient-derived cancer stem-like cells in head and neck squamous carcinomas.
Sun S; Liu S; Duan SZ; Zhang L; Zhou H; Hu Y; Zhou X; Shi C; Zhou R; Zhang Z
Cancer Res; 2014 Dec; 74(24):7546-59. PubMed ID: 25320014
[TBL] [Abstract][Full Text] [Related]
2. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB
Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308
[No Abstract] [Full Text] [Related]
3. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
4. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
[TBL] [Abstract][Full Text] [Related]
5. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
[No Abstract] [Full Text] [Related]
6. Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions.
Le PN; Keysar SB; Miller B; Eagles JR; Chimed TS; Reisinger J; Gomez KE; Nieto C; Jackson BC; Somerset HL; Morton JJ; Wang XJ; Jimeno A
Mol Carcinog; 2019 Mar; 58(3):398-410. PubMed ID: 30378175
[TBL] [Abstract][Full Text] [Related]
7. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.
Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL
Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013
[TBL] [Abstract][Full Text] [Related]
9. A new gamboge derivative compound 2 inhibits cancer stem-like cells via suppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma.
Deng R; Wang X; Liu Y; Yan M; Hanada S; Xu Q; Zhang J; Han Z; Chen W; Zhang P
J Cell Mol Med; 2013 Nov; 17(11):1422-33. PubMed ID: 24112466
[TBL] [Abstract][Full Text] [Related]
10. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
Khammanivong A; Gopalakrishnan R; Dickerson EB
Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
[TBL] [Abstract][Full Text] [Related]
11. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
[TBL] [Abstract][Full Text] [Related]
12. The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model.
Sampson ER; Martin BA; Morris AE; Xie C; Schwarz EM; O'Keefe RJ; Rosier RN
J Bone Miner Res; 2011 Jun; 26(6):1283-94. PubMed ID: 21308771
[TBL] [Abstract][Full Text] [Related]
13. Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling.
Rajamoorthi A; Shrivastava S; Steele R; Nerurkar P; Gonzalez JG; Crawford S; Varvares M; Ray RB
PLoS One; 2013; 8(10):e78006. PubMed ID: 24147107
[TBL] [Abstract][Full Text] [Related]
14. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
[TBL] [Abstract][Full Text] [Related]
15. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic target for head and neck squamous cell carcinoma: HGF-MET signaling pathway.
Lau PC; Chan AT
Anticancer Drugs; 2011 Aug; 22(7):665-73. PubMed ID: 21709616
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells in head and neck squamous cell carcinoma: a review of current knowledge and future applications.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Head Neck; 2012 Jun; 34(6):894-9. PubMed ID: 21850700
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152.
Wang Y; Wang S; Wu Y; Ren Y; Li Z; Yao X; Zhang C; Ye N; Jing C; Dong J; Zhang K; Sun S; Zhao M; Guo W; Qu X; Qiao Y; Chen H; Kong L; Jin R; Wang X; Zhang L; Zhou J; Shen Q; Zhou X
Mol Cancer Ther; 2017 Apr; 16(4):578-590. PubMed ID: 28138036
[TBL] [Abstract][Full Text] [Related]
19. A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma.
Kong LR; Mohamed Salleh NAB; Ong RW; Tan TZ; Syn NL; Goh RM; Fhu CW; Tan DSW; Iyer NG; Kannan S; Verma CS; Lim YC; Soo R; Ho J; Huang Y; Lim JSJ; Yan BJ; Nga ME; Lim SG; Koeffler HP; Lee SC; Kappei D; Hung HT; Goh BC
Nat Commun; 2020 Mar; 11(1):1556. PubMed ID: 32214092
[TBL] [Abstract][Full Text] [Related]
20. Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis.
Sun S; Wang Z
Int J Cancer; 2011 Nov; 129(10):2337-48. PubMed ID: 21225626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]